Glucose Health, Inc. (GLUC) Return on Investment ROI from the third quarter of 2017 to third quarter of 2016 and for the year 2017, average high and low, overall ranking from Sep 30 2017 to Sep 30 2016 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Glucose Health, Inc.  (GLUC)


Glucose Health,'s ROI from its third quarter of 2017 to the third quarter of 2016 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Glucose Health,'s ROI in the third quarter of 2017?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Glucose Health, Inc.'s return on investment (ROI) in its third quarter of 2017

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2017)
III. Quarter		 (Jun 30 2017)
II. Quarter		 (Mar 31 2017)
I. Quarter		 (Dec 31 2016)
IV. Quarter		 (Sep 30 2016)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 0 -1 0 0
Return On Investment (TTM) - - - - -
GLUC's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

GLUC Company Profile >> Back to GLUC Roi Comparisons >> See Annual GLUC Return On Investment



Return On Investment GLUC's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Glucose Health,'s III. Quarter Investments $ 0 Millions GLUC's Balance sheet
Glucose Health,'s III. Quarter Income $ 0 Millions Quarterly GLUC's Income Statement
GLUC's Income by Division See GLUC's Income by Division


GLUC Annual Return On Investment (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012
Total Investments in Millions 0 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 0 0 -1 -1 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - - - -1824.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GLUC's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GLUC's Competitors
Subscribers only: Roi for Glucose Health,'s Suppliers
Subscribers only: Return On Investment for GLUC's Customers

Other Ratios
GLUC's Roa GLUC's Inventory Turnover Ratio GLUC's Growth Rates GLUC's Dividend Statistics
GLUC's Profitability Ratios GLUC's Asset Turnover Ratio GLUC's Dividend Growth
GLUC's Roe GLUC's Valuation Ratios GLUC's Financial Strength Ratios GLUC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2017, within Healthcare Sector ROI
Corcept Therapeutics Inc  58.16 %
Mimedx Group Inc   54.00 %
Masimo Corp  50.34 %
Integrated Biopharma Inc  50.22 %
Eagle Pharmaceuticals inc   49.92 %
Ligand Pharmaceuticals Incorporated  48.08 %
Elite Pharmaceuticals Inc   46.42 %
Lisata Therapeutics Inc   45.05 %
Sonoma Pharmaceuticals Inc   43.09 %
Pro dex Inc   41.54 %
Cba Florida Inc   37.72 %
Exelixis Inc   36.99 %
Luna Innovations Inc  34.62 %
Cryo cell International Inc   32.21 %
Iveric Bio Inc   29.71 %
Psychemedics Corporation  29.64 %
Innoviva Inc   28.25 %
Remedent Inc   26.57 %
Opiant Pharmaceuticals Inc   26.28 %
Mettler toledo International Inc   25.98 %
Idexx Laboratories Inc  25.26 %
United Therapeutics Corporation  25.07 %
Align Technology inc   24.91 %
Nrc Health  24.00 %
Alpha Pro Tech Ltd   23.24 %
Supernus Pharmaceuticals inc   22.94 %
Gilead Sciences Inc   22.51 %
Lineage Cell Therapeutics Inc   21.72 %
3m Company  19.80 %
Healthcare Services Group Inc   19.31 %

Date modified: 2026-09-08T15:09:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.